Marion Mccourt

Biography

Ms. Marion McCourt has served as president and chief operating officer of Axovant Sciences, Inc. since April 2017. She has more than two decades of wide-ranging experience at some of the world’s most innovative biopharmaceutical companies. She has extensive experience leading commercial functions including medical affairs, business development, finance, human resources, legal, operations, payer-government, and sales and marketing. Before joining Axovant, she was Chief Operating Officer of Medivation, Inc. until its acquisition by Pfizer Inc. Earlier in her career, she held multiple roles at Amgen including Vice President in US Commercial Operations and Vice President and General Manager at Amgen, where she was responsible for the bone health and primary care business unit. She served in a number of roles of increasing responsibility during a 12-year career at AstraZeneca including ultimately as Chief Operating Officer for AstraZeneca US. She received a BS in biology from Lafayette College.

Research Interest

medical affairs, business development, finance, human resources, legal, operations, sales and marketing, neurology, CNS drugs, biology.